Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017 (2017), Article ID 1218254, 8 pages
https://doi.org/10.1155/2017/1218254
Research Article

Clinical Significance and Prognostic Value of the Expression of LAMP3 in Oral Squamous Cell Carcinoma

1Department of Stomatology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China
2Department of Pathology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China

Correspondence should be addressed to Jianfei Huang; moc.621@rotcodyytn and Xingmei Feng; moc.621@tniemgnixgnef

Received 23 January 2017; Revised 5 April 2017; Accepted 30 April 2017; Published 18 May 2017

Academic Editor: Eric A. Singer

Copyright © 2017 Jun Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Perez-Sayans, J. M. Somoza-Martin, F. Barros-Angueira, M. D. Reboiras-López, J. M. Gándara Rey, and A. García-García, “Genetic and molecular alterations associated with oral squamous cell cancer (review),” Oncology Reports, vol. 22, no. 6, pp. 1277–1282, 2009. View at Google Scholar
  2. A. K. Markopoulos, “Current aspects on oral squamous cell carcinoma,” The Open Dentistry Journal, vol. 6, no. 1, pp. 126–130, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, “Global cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. E. P. Simard, L. A. Torre, and A. Jemal, “International trends in head and neck cancer incidence rates: differences by country, sex and anatomic site,” Oral Oncology, vol. 50, no. 5, pp. 387–403, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. D. G. Pfister, S. Spencer, D. M. Brizel et al., “Head and neck cancers, version 1.2015,” Journal of the National Comprehensive Cancer Network, vol. 13, no. 7, pp. 847–855, 2015, quiz 856. View at Publisher · View at Google Scholar
  6. W. Jerjes, T. Upile, A. Petrie et al., “Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients,” Head & Neck Oncology, vol. 2, no. 1, p. 9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Al-Rajhi, Y. Khafaga, J. El-Husseiny et al., “Early stage carcinoma of oral tongue: prognostic factors for local control and survival,” Oral Oncology, vol. 36, no. 6, pp. 508–514, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. P. J. Slootweg, G. J. Hordijk, Y. Schade, R. J. van Es, and R. Koole, “Treatment failure and margin status in head and neck cancer. A critical view on the potential value of molecular pathology,” Oral Oncology, vol. 38, no. 5, pp. 500–503, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Warnakulasuriya, “Global epidemiology of oral and oropharyngeal cancer,” Oral Oncology, vol. 45, no. 4-5, pp. 309–316, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Zhang, P. T. Dziegielewski, V. L. Biron et al., “Survival outcomes of patients with advanced oral cavity squamous cell carcinoma treated with multimodal therapy: a multi-institutional analysis,” Journal of Otolaryngology - Head & Neck Surgery, vol. 42, no. 1, p. 30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. B. de Saint-Vis, J. Vincent, S. Vandenabeele et al., “A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment,” Immunity, vol. 9, no. 3, pp. 325–336, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Liao, Y. Chen, D. Liu, F. Li, X. Li, and W. Jia, “High expression of LAMP3 is a novel biomarker of poor prognosis in patients with esophageal squamous cell carcinoma,” International Journal of Molecular Sciences, vol. 16, no. 8, pp. 17655–17667, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Sun, X. Wang, H. Zhu et al., “Prognostic value of LAMP3 and TP53 overexpression in benign and malignant gastrointestinal tissues,” Oncotarget, vol. 5, no. 23, pp. 12398–12409, 2014. View at Publisher · View at Google Scholar
  14. A. Nagelkerke, J. Bussink, H. Mujcic et al., “Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response,” Breast Cancer Research, vol. 15, no. 1, p. R2, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Nagelkerke, H. Mujcic, J. Bussink et al., “Hypoxic regulation and prognostic value of LAMP3 expression in breast cancer,” Cancer, vol. 117, no. 16, pp. 3670–3681, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Kanao, T. Enomoto, T. Kimura et al., “Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer,” Cancer Research, vol. 65, no. 19, pp. 8640–8645, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Qiu, Y. You, J. Huang, X. Wang, H. Zhu, and Z. Wang, “LAMP3 and TP53 overexpression predicts poor outcome in laryngeal squamous cell carcinoma,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 5, pp. 5519–5527, 2015. View at Google Scholar
  18. H. Mujcic, T. Rzymski, K. M. Rouschop et al., “Hypoxic activation of the unfolded protein response (UPR) induces expression of the metastasis-associated gene LAMP3,” Radiotherapy and Oncology, vol. 92, no. 3, pp. 450–459, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Mujcic, A. Nagelkerke, K. M. Rouschop et al., “Hypoxic activation of the PERK/eIF2α arm of the unfolded protein response promotes metastasis through induction of LAMP3,” Clinical Cancer Research, vol. 19, no. 22, pp. 6126–6137, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Zhai, H. Zhu, W. Wang, S. Zhang, Y. Zhang, and G. Mao, “Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC,” Medical Oncology, vol. 31, no. 6, p. 970, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Lian, X. Zhai, X. Wang et al., “Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer,” Medicine (Baltimore), vol. 95, no. 30, article e4328, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Han, M. M. Tang, X. Xu et al., “LTBP2 is a prognostic marker in head and neck squamous cell carcinoma,” Oncotarget, vol. 7, no. 29, pp. 45052–45059, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Harada, Y. Kawashima, H. Yoshida, and M. Sato, “Thymidylate synthase expression in oral squamous cell carcinoma predicts response to S-1,” Oncology Reports, vol. 15, no. 6, pp. 1417–1423, 2006. View at Google Scholar
  24. L. P. Kalinke, L. E. Alvares, J. L. Schussel et al., “Expression of WNT10A gene in oral squamous cell carcinoma,” The West Indian Medical Journal, vol. 65, no. 3, 2016. View at Publisher · View at Google Scholar
  25. I. Treilleux, J. Y. Blay, N. Bendriss-Vermare et al., “Dendritic cell infiltration and prognosis of early stage breast cancer,” Clinical Cancer Research, vol. 10, no. 22, pp. 7466–7474, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Ferlay, I. Soerjomataram, R. Dikshit et al., “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012,” International Journal of Cancer, vol. 136, no. 5, pp. E359–E386, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Kang, A. Kiess, and C. H. Chung, “Emerging biomarkers in head and neck cancer in the era of genomics,” Nature Reviews. Clinical Oncology, vol. 12, no. 1, pp. 11–26, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. J. C. Lee, K. C. Chiang, T. H. Feng et al., “The iron chelator, Dp44mT, effectively inhibits human oral squamous cell carcinoma cell growth in vitro and in vivo,” International Journal of Molecular Sciences, vol. 17, no. 9, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Hwang-Bo, J. H. Park, M. G. Bae, and I. S. Chung, “Recombinant canstatin inhibits VEGF-A-induced lymphangiogenesis and metastasis in an oral squamous cell carcinoma SCC-VII animal model,” Cancer Medicine, vol. 5, no. 10, pp. 2977–2988, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Chen, J. H. Shin, J. T. Eggold et al., “ESM1 mediates NGFR-induced invasion and metastasis in murine oral squamous cell carcinoma,” Oncotarget, vol. 7, no. 43, pp. 70738–70749, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Straub, E. Drecoll, N. Pfarr et al., “CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity,” Oncotarget, vol. 7, no. 11, pp. 12024–12034, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Kumar, S. Mehra, A. Thakar et al., “End binding 1 (EB1) overexpression in oral lesions and cancer: a biomarker of tumor progression and poor prognosis,” Clinica Chimica Acta, vol. 459, pp. 45–52, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Saghravanian, M. Zamanzadeh, Z. Meshkat, M. Afzal Aghaee, and R. Salek, “Evaluation of the prevalence rate and the prognostic effect of human papilloma virus infection in a group of patients with oral cavity squamous cell carcinoma,” Iran Journal of Cancer Prevention, vol. 9, no. 3, article e3998, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. S. R. Carlsson and M. Fukuda, “The lysosomal membrane glycoprotein lamp-1 is transported to lysosomes by two alternative pathways,” Archives of Biochemistry and Biophysics, vol. 296, no. 2, pp. 630–639, 1992. View at Publisher · View at Google Scholar · View at Scopus
  35. O. Saitoh, W. C. Wang, R. Lotan, and M. Fukuda, “Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials,” The Journal of Biological Chemistry, vol. 267, no. 8, pp. 5700–5711, 1992. View at Google Scholar
  36. K. Ozaki, M. Nagata, M. Suzuki et al., “Isolation and characterization of a novel human lung-specific gene homologous to lysosomal membrane glycoproteins 1 and 2: significantly increased expression in cancers of various tissues,” Cancer Research, vol. 58, no. 16, pp. 3499–3503, 1998. View at Google Scholar
  37. J. A. Dominguez-Bautista, M. Klinkenberg, N. Brehm et al., “Loss of lysosome-associated membrane protein 3 (LAMP3) enhances cellular vulnerability against proteasomal inhibition,” European Journal of Cell Biology, vol. 94, no. 3-4, pp. 148–161, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Nagelkerke, A. M. Sieuwerts, J. Bussink et al., “LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagy,” Endocrine-Related Cancer, vol. 21, no. 1, pp. 101–112, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Matta, R. Ralhan, L. V. DeSouza, and K. W. Siu, “Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery,” Mass Spectrometry Reviews, vol. 29, no. 6, pp. 945–961, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Kaur, M. Sawhney, S. DattaGupta et al., “Clinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression,” PloS One, vol. 8, no. 6, article e67361, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Siegel, J. Ma, Z. Zou, and A. Jemal, “Cancer statistics, 2014,” CA: A Cancer Journal for Clinicians, vol. 64, no. 1, pp. 9–29, 2014. View at Publisher · View at Google Scholar · View at Scopus